Annual report [Section 13 and 15(d), not S-K Item 405]

Statement of Changes in Stockholders' Equity

v3.25.4
Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     26,329,032        
Beginning balance at Dec. 31, 2023 $ 15,937   $ 3   $ 52,759   $ (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 4,299       4,299    
Sale of Common Stock, net of issuance costs (in shares)     309,634        
Sale of Common Stock, net of issuance costs $ 730       730    
Stock issuance upon exercise of stock options (in shares) 144,408   144,408        
Stock issuance upon exercise of stock options $ 136       136    
Stock issuance upon vesting of restricted stock units (in shares)     177,827        
Net Income (Loss) $ (19,448)           (19,448)
Ending balance (in shares) at Dec. 31, 2024 26,960,901   26,960,901        
Ending balance at Dec. 31, 2024 $ 1,654   $ 3   57,924   (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 5,147       5,147    
Sale of Common Stock, net of issuance costs (in shares)     6,746,386 5,859,704      
Sale of Common Stock, net of issuance costs $ 10,250 $ 6,328   $ 1 10,250 $ 6,327  
Stock issuance upon exercise of stock options (in shares) 89,784   58,240        
Stock issuance upon exercise of stock options $ 13       13    
Stock issuance upon vesting of restricted stock units (in shares)     394,278        
Stock issuance for services, shares 97,895   97,895        
Stock issuance for services, amount $ 226       226    
Net Income (Loss) $ (21,015)           (21,015)
Ending balance (in shares) at Dec. 31, 2025 26,960,901   40,117,404        
Ending balance at Dec. 31, 2025 $ 2,603   $ 4   $ 79,887   $ (77,288)